ArcticZymes Technologies ASA (AZT.OL)
NOK 13.58
(-2.3%)
NOK 13.58
(-2.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 15.74 Million NOK | -56.74% |
| 2022 | 36.47 Million NOK | -37.58% |
| 2021 | 58.43 Million NOK | 36.55% |
| 2020 | 42.79 Million NOK | 843.32% |
| 2019 | -5.75 Million NOK | 59.36% |
| 2018 | -14.16 Million NOK | 43.14% |
| 2017 | -24.91 Million NOK | -18.89% |
| 2016 | -20.95 Million NOK | -21.04% |
| 2015 | -17.31 Million NOK | 26.75% |
| 2014 | -23.63 Million NOK | 0.76% |
| 2013 | -23.81 Million NOK | 3.69% |
| 2012 | -24.72 Million NOK | -16.66% |
| 2011 | -21.19 Million NOK | 27.62% |
| 2010 | -29.28 Million NOK | 65.6% |
| 2009 | -85.12 Million NOK | 6.78% |
| 2008 | -91.31 Million NOK | -260.15% |
| 2007 | 57.01 Million NOK | 583.32% |
| 2006 | 8.34 Million NOK | -84.95% |
| 2005 | 55.45 Million NOK | 1848533.33% |
| 2004 | 3000.00 NOK | -99.99% |
| 2003 | 57.19 Million NOK | 928.13% |
| 2002 | 5.56 Million NOK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 728 Thousand NOK | 47.07% |
| 2024 Q2 | 1.12 Million NOK | 54.26% |
| 2023 Q2 | 5.18 Million NOK | 14.45% |
| 2023 Q1 | 4.52 Million NOK | -25.71% |
| 2023 Q4 | 495 Thousand NOK | -91.25% |
| 2023 FY | 15.77 Million NOK | -56.74% |
| 2023 Q3 | 5.65 Million NOK | 9.15% |
| 2022 Q1 | 26.74 Million NOK | 33.88% |
| 2022 Q2 | 8.27 Million NOK | -69.06% |
| 2022 FY | 36.47 Million NOK | -37.58% |
| 2022 Q3 | 1.53 Million NOK | -81.51% |
| 2022 Q4 | 6.09 Million NOK | 298.3% |
| 2021 Q3 | 8.08 Million NOK | 55.78% |
| 2021 Q2 | 5.19 Million NOK | -79.39% |
| 2021 FY | 58.43 Million NOK | 36.55% |
| 2021 Q1 | 25.18 Million NOK | 564.68% |
| 2021 Q4 | 19.97 Million NOK | 147.09% |
| 2020 FY | 42.79 Million NOK | 843.32% |
| 2020 Q4 | -5.41 Million NOK | -159.26% |
| 2020 Q3 | 9.14 Million NOK | -65.19% |
| 2020 Q2 | 26.26 Million NOK | 105.19% |
| 2020 Q1 | 12.8 Million NOK | 562.92% |
| 2019 Q1 | -5.27 Million NOK | -140.84% |
| 2019 FY | -5.75 Million NOK | 59.36% |
| 2019 Q4 | 1.93 Million NOK | 471.35% |
| 2019 Q3 | -520 Thousand NOK | 72.57% |
| 2019 Q2 | -1.89 Million NOK | 64.04% |
| 2018 FY | -14.16 Million NOK | 43.14% |
| 2018 Q1 | -6.43 Million NOK | 17.9% |
| 2018 Q4 | -2.18 Million NOK | -181.36% |
| 2018 Q3 | -778 Thousand NOK | 83.69% |
| 2018 Q2 | -4.76 Million NOK | 25.84% |
| 2017 Q3 | -7.7 Million NOK | -60.39% |
| 2017 Q2 | -4.8 Million NOK | -5.05% |
| 2017 Q1 | -4.57 Million NOK | 40.96% |
| 2017 FY | -24.91 Million NOK | -18.89% |
| 2017 Q4 | -7.83 Million NOK | -1.66% |
| 2016 Q4 | -7.74 Million NOK | -20.39% |
| 2016 Q3 | -6.43 Million NOK | -210.97% |
| 2016 Q1 | -3.97 Million NOK | 50.14% |
| 2016 Q2 | -2.06 Million NOK | 47.96% |
| 2016 FY | -20.95 Million NOK | -21.04% |
| 2015 Q2 | -1.68 Million NOK | 51.17% |
| 2015 FY | -17.31 Million NOK | 26.75% |
| 2015 Q4 | -7.97 Million NOK | -89.86% |
| 2015 Q1 | -3.45 Million NOK | 45.36% |
| 2015 Q3 | -4.2 Million NOK | -149.11% |
| 2014 Q4 | -6.32 Million NOK | 5.13% |
| 2014 FY | -23.63 Million NOK | 0.76% |
| 2014 Q3 | -6.66 Million NOK | -126.14% |
| 2014 Q2 | -2.94 Million NOK | 61.77% |
| 2014 Q1 | -7.7 Million NOK | -11.71% |
| 2013 Q3 | -4.98 Million NOK | 5.84% |
| 2013 Q4 | -6.89 Million NOK | -38.49% |
| 2013 FY | -23.81 Million NOK | 3.69% |
| 2013 Q1 | -6.64 Million NOK | 3.46% |
| 2013 Q2 | -5.29 Million NOK | 20.4% |
| 2012 Q1 | -4.95 Million NOK | 29.38% |
| 2012 Q4 | -6.88 Million NOK | 1.28% |
| 2012 Q3 | -6.97 Million NOK | -17.87% |
| 2012 FY | -24.72 Million NOK | -16.66% |
| 2012 Q2 | -5.91 Million NOK | -19.44% |
| 2011 Q4 | -7.01 Million NOK | -23.57% |
| 2011 Q1 | -3.17 Million NOK | -46.0% |
| 2011 Q2 | -5.32 Million NOK | -67.71% |
| 2011 Q3 | -5.67 Million NOK | -6.53% |
| 2011 FY | -21.19 Million NOK | 27.62% |
| 2010 Q4 | -2.17 Million NOK | 72.96% |
| 2010 Q2 | -5.97 Million NOK | 54.24% |
| 2010 Q1 | -13.05 Million NOK | 0.0% |
| 2010 Q3 | -8.04 Million NOK | -34.68% |
| 2010 FY | -29.28 Million NOK | 65.6% |
| 2009 FY | -85.12 Million NOK | 6.78% |
| 2008 FY | -91.31 Million NOK | -260.15% |
| 2007 FY | 57.01 Million NOK | 583.32% |
| 2006 FY | 8.34 Million NOK | -84.95% |
| 2005 FY | 55.45 Million NOK | 1848533.33% |
| 2004 FY | 3000.00 NOK | -99.99% |
| 2003 FY | 57.19 Million NOK | 928.13% |
| 2002 FY | 5.56 Million NOK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Arctic Bioscience AS | -48.58 Million NOK | 132.408% |
| Aqua Bio Technology ASA | -17.85 Million NOK | 188.178% |
| BerGenBio ASA | -191.81 Million NOK | 108.209% |
| Hofseth BioCare ASA | -102.52 Million NOK | 115.358% |
| PCI Biotech Holding ASA | -22.24 Million NOK | 170.797% |
| Thor Medical ASA | -7.16 Million NOK | 319.916% |
| Ultimovacs ASA | -215.73 Million NOK | 107.299% |